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Abstract: N-3 fatty acids, such as fish oil, have been reported to have some beneficial
effects in patients with bronchial asthma by suppressing leukocyte function, followed by
reduction of the need for pharmacologic agents. To examine the effects of dietary
supplementation with perilla seed oil rich in a -linolenic acid (ALA), 23 patients with
asthma took corn oil rich in linoleic acid (LA) for the former two weeks, perilla seed oil
for the later two weeks. The asthmatic patients were classified into two groups by the
changes of the generation of leukotrienes 84 (LT84), C4 (LTC4), and 85 (LT85) during
the two courses of dietary modification: one was sensitive to dietary modification, and
the other was insensitive to dietary supplementation. We compared the two groups in
clinical characteristics. Significant differences were observed in peak flow (PEF), forced
expiratory volume in one second (FEV1.0), IgE, sex, obesity index (01), concentration of
serum total cholesterol, albumin, low density lipoprotein {LDL)-cholesterol, P-
lipoprotein and phospholipids between two groups.
This study indicated that these factors influence the generation of LT84, C4 and 85 of
asthmatic patients in dietary supplementation.
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Introduction
Bronchial asthma is characterized by airway inflam-
mation, by bronchial hyperresponsiveness to non-
specific stimuli, and episodic and reversible airflow
obstruction. Airway inflammation may be central to
pathophysiology of bronchial asthma.
Leukotrienes (LTs) are one of the most important
chemical mediators released from inflammatory cells,
which are involved in the pathogenesis of bronchial
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asthma. Peptide LTs (LTC4, D4 and E4) have a
bronchoconstrictor action and participate in the onset
of asthma attacksl)2).
LTB4 plays an important role in the process of
asthmatic response by recruiting leukocytes to allergic
reaction sites in the airway. These LTs are generated
from arachidonic acid (AA), which is released from
membrane phospholipids during cell activation, th-
rough the 5-lipoxygenase pathway3).
LTB4 and LTC4 are generated from LA through
AA and that LTB5 from LA through eicosapentaenoic
acid (EPA) in same 5-Iipoxygenase pathway. Perilla
seed oil-rich supplementation containing much ALA
have been expected to suppress the LTs generation by
leukocytes and increase the generation of LTB5. As
the same reason, com oil-rich supplementation con-
taining much LA are supposed to increase the genera-
tion ofLTB4 and LTC4 and decrease thegeneration of
LTB5 by leukocytes.
Polyunsaturated fatty acids (PUFA) of the n-3 series
-EPA and docosahexaenoic acid (DHA)-suppress the
production of LTs by antagonistic metabolism, which
is occured at the level of LT hydrolase through the
5-Iipoxygenase pathway and therefore they have a
potential to alter LTs generation by leulocytes. These
PUFAs have been reported to show an antiinf-
lammatory effects in patients with chronic inflam-
matory diseases such as rheumatoid arthritis, psoriasis,
and chronic inflammatory bowel disease4)-lOl.
Several reports have focused the beneficial effects of
EPA or fish oil on bronchial asthmalll-14). In contrast,
other several reports have not demonstrated the benefi-
cial effects of EPA in patients with bronchial asth-
maI5)16l.
In previous studyl?), we examined the effectiveness
of a diet containing perilla seed oil, a vegetable oil rich
in ALA for inhibition of LT generation. Perilla seed
oil has a large amount of ALA compared with com oil
rich in LA.
In this study, we examined the effects of perilla seed
oil supplementation in patients with asthma to show
the importance of the quality of the fatty acid that
influences a ratio between n-6 and n-3 fatty acids (n-6:
n-3) by affecting the LTs generation by leulocytes.
Subjects and Methods
Subjects
The subjects of this study were 23 patients (15
females and 8 males) with asthma. All patients were
admitted to Misasa Branch Hospital for treatment of
asthma. Their mean age was 57.4 years (ranged from
22 to 73 years) and the mean of serum IgE was
460.5IU/ml (ranged from 16.4 to 2811IU/ml).
Bronchial asthma was evaluated according to the
criteria of the International Consensus of Diagnosis
and Management of Asthmal8l. All patients revealed
reversible airway response with a difference between
prebronchodilator and postbronchodilator values of
FEVI.O exceeding 15%. An inforned concent for study
protocol was obtained from all patients. All patients
had been taking long-acting oral theophyline, inhaled
f3 2 adrenergic agonists and inhaled glucocorticos-
teroid (beclomethasone) regularly.
Clinical symptoms, such as cough, wheeze, daytime
activity, volume of sputum and dyspnea were observed
daily and assessed by a score according to the
evaluation system developped by the Committee of the
Japanese Society of Allergology. Peak flow in the
early morning and evening was recorded in all subjects
using peak-flow meter (Assess: Health Scan Products
Inc., Cedar Grove, NJ, USA).
The following parameters were evaluated by a
formula described below.
Standard body weight(kg) = {body height (em) -IIO}
x 0.9
01(%)=(body weight) (kg) I (standard body weight)
(kg) x 100
Body mass index(BMI)=[{body weight(kg)} I {body
height(m)} 2)xloo
The concentration of the serum total cholesterol,
triglyceride, high density lipoprotein (HDL)-choles-
terol, free fatty acid and phospholipid were assayed by
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a enzyme (cholesterol oxydase) method. The concen-
tration of the serum total protein was assayed by
Biuret method and the concentrations of the serum
albumin and alubumunlgloburin ratio (AiG ratio) were
assayed by BCG method + Biuret method. LDL-
cholesterol was calculateed from the formula [(serum
total cholesterol) - (HDL - cholesterol) - 0.2 x
(triglyceride)] (Friedwald's convert)19)
Serum IgE level was examined by radioimmu-
nosorbent test (RIST).
Pulmonary function tests, %forced vital capacity
(%VC), FEV1.0, V25, residual volume (RV)and %dif-
fusing capacity of lung (%DLco) were performed by
CHESTAC33 (Chest Co. Tokyo, Japan) linked to a
computer, when they were attack free.
The generation of LTB4, LTC4 and LTB5 by
perioheral leukocytes was assessed by a method
previously described20)21). Cells were separated by
counterflow centrifugation elutriation with a JE6B
rotor (Beckman Co. Geneva, Switzerland)22), as de-
scribed previously23). After the number of the cells was
adjusted to 5x106/ml in Tris ACM (composition: lrnl
of 0.1 mol/lCa2+, O.5rnl of 0.1 moUI Mg2+ and 98.5ml
Tris A buffer; Trizma preset crystal, pH7.7; Sigma
Chemical Co., St. Louis, Mo, USA). Ca ionophore
A23187 (l f1 g) was added to the cell suspention. The
mixed solution was incubated for 15 min at 4 'C The
HPLC analysis for extraction and quantification of
LTB4, LTC4 and LTB5 was performed by a method
described by Lam et al.24l. The extraction of LTs was
performed using a C18 Seppak (Waters Associates).
The concentrations of LTB4, LTC4 and LT B5 were
analysed by HPLC system, Model 510 (Waters As-
sociates), equipped with an ultraviolet detector. The
column used was a 5rnm x IDem Radial-Pax cartridge
(Shimazu Co. Kyoto, Japan). The results were ex-
pressed as ng/5xI06cells.
The subjects took 10-20 gram of com oil per day as
salad dressing and lor mayonnaise instead of other oils
for the former 2 weeks and the same dosage of perilla
seed oil per day for the later 2 weeks. Other dietary
components were not changed and the amount of oil
used in the diet and supplemented diet was recorded
tthroughout the study period.
We classified the subjects into 2 groups by the
generation of LTB4, C4 and B5. After administration
of com oil for 2 weeks, an increase of generation of
LTB4 or LTC4 or decrease of the generation of LTB5
was counted as score I. After supplementation perilla
seed oilfor 2 weeks, the decrease of the generation of
LTB4 or LTC4 or the increase of the generation of
LTB5 was counted as score I. The group of the total
score more than 3 was evaluated as "sensitive to diet",
and the group of the total score less than 3 was
evaluated "insensitive to diet".
Data are expressed as mean ± standard deviation.
Statistically significant differences between means
were estimated using the unpaired Student's t-test. A P
value of <0.05 was regarded as significant.
Results
The group of the "sensitive to diet" included 5
females and 8 males. The mean age of the group was
54.5 years (ranged from 22 to 72 years). Ten subjects
of the "insensitive to diet" were all females. The mean
age of the group was 61.2 years (ranged from 55 to 73
years).
As the clinical backgrounds of the two groups given
in Table I shows that the number of the male, height
and serum IgE levels were significantly higher, and
obesity index was significantly lower in the "sensitive
to diet" group compared with those in the "insensitive
to diet" group. However, there were not significantly,
differences in age at onset and BMI between the two
groups. The difference of the height might depend on
the different number of male between the two groups.
The generation of LTB4, C4 and B5 by leukocytes
were shown in Fig. I, 2, and 3. LTs generation
beforethe beginning of this study was higher in the
"sensitive to diet" group was than that in the "insensit-
ive to diet" group. In the "sensitive to diet" group, the
generation of LTC4 after com oil-rich supplementa-
tion (Fig.2) and the generation of LTB5 after the two
43 The clinical effects of dietary supplementation with n-3 fatty acids in bronchial asthma compared
Table I The clinical differences in sex, onset age, age, ,.
weight, IgE, height, BMI and 01 between the 2 12
groups. '0
i 8 t--------.1-_i!: ___
~§ 4
sex(female/male)**
onset age(year)
age(year)
weight(ke)
IgE(IU/mG)*
height(an)**
BMI(%)
01(%)*
"sensitive to diet"
13(5/8)
36.3±19.8
54.5±17.0
58.7±10.8
696.0±858.3
159±8.9
23.2±3.9
111.6±20.3
"insensitive to diet"
10(10/0)
47.1 ±15.1
61.2±5.8
60.8±16.4
154.5±125.9
151.3±4.7
26.5±6.5
131.7±31.2
before periII. seed
oil-rich
suppleTlentation
aft" perila seed
-'"
--
"Q
,.0
Fig 1. The changes of LTB4 in the 2 groups during 2
different courses of dietary supplementation.
LTB4 generation in the "sensitive toi diet" group
( • ) was higher than that in the "insensitive to
diet" group ( • ).
Fig 3. The changes of LTB5 in the 2 groups during 2
different courses of dietary supplementation.
LTB5 generation in the "sensitive to diet" group
( • ) was higher than that in the "insensitive to
diet" group ( • ).
kinds of supplementation (Fig.3) were larger com-
pared with the generation in the "insensitive to diet"
group.
In respiratory function, PEF in the morning and
evening and FEVI.O values before inhalation of f3 2
agonist significantly more increased in the "sensitive
to diet" group compared with the "insensitive to diet"
group (Table 2). No significant differences in %VC,
FEVI.O%, RV and DLco values were observed be-
tween the two groups.
before petillaselld
oil-rich
SlJpplement.tlon
~cort'loil-rictl
supplementation
100
! 80
'; 60
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Table 2 The differences in respiratory functions
between the 2 groups.
"sensitive to diet" "insensitiVe to diet"
Symptomatic score (SS), Therapeutic score (TS)
and Asthmatic score (AA) were not significantly
different between the 2 groups (Table 3). Regarding to
lipometabolism, the "sensitive to diet" group showed
-'a
befor_ periUa$fe
.-supplementatkln
Fig 2. The changes of LTC4 in the 2 groups during 2
different courses of dietary supplementation.
LTC4 generation in the "sensitive to diet" group
( • ) was higher than that in the "insensitive to
diet" group. ( • ).
PEF(moming)( O/min)*
PEF(evening)( O/min)*
%VC(%)
FEV1.0( 0)*
FEV1.0%(%)
V25(O)
%V25(%)
RV(O)
%DLCO(%)
266.8± 11 0.1
295.7±122.6
93.43±21.40
1.90±0.80
76.55±25.42
0.60±0.57
29.33±21.70
4.22±6.52
89.38±22.93
189.0±88.9
226.0±63.5
93.99±16.99
1.48±0.31
79.74±13.39
0.48±0.27
32.54±20.28
1.75±0.52
94.03±19.60
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Table 3 The differences in asthmatic severity between
the 2 groups.
Table 4 The lipometabolic differences between the 2
groups.
significantly lower levels of total cholesterol, LDL
-cholesterol, {3 -lipoprotein and phosphlipid, and sig-
nificantly higher levels of serum albumin compared
with the levels in the "insensitive to diet" group (Table
4). No significant differences were observed in serum
total protein and NG ratio between the two groups.
Bronchial allergen challenge induces an immediate
asthmatic reaction (JAR) within 30 minutes and a late
asthmatic reaction (LAR), in which occurs 6-8 hours
after the challenge. The LAR, in which inflammatory
cells such as lymphocytes, neutrophils, eosinophils
and basophils migrate into allergic reaction sites in the
airway2)2S), is closely associated with bronchial hy-
perresponsiveness26)27). LTs are one of the major
chemical mediators in asthma and play important roles
in theLAR.
LTs are synthesized by inflammatory cells in large
amounts during allergic reactions. The generation of
LTB4 is reduced by n-3 fatty acids28)29). LTB4
generation from LA and LTB5 from ALA have similar
biological activities. However, the action of LTB5 is
much weaker than that of LTB4. The cysteinyl LTs
(LTC4, LTD4 and LTE4) are implicated in the
pathogenesis of allergen-induced airway responsive-
ness as potent contractile agonists for airway smooth
muscle by mediating a later part of immediate airway
obstruction-fall in FEV1.0- after allergen exposure30)31.
In this study, the "sensitive to diet" group showed
significantly higher values of FEV1.0 and PEF com-
pared with the values in the "insensitive to diet" group.
The results show that the "sensitive to diet" group had
clinically better states of bronchial asthma than the
"insensitive to diet" group and that cysteinyl LTs
might affect respiratory function as expiratory FEVI.O
and PEF in asthmatic patients.
LTs, as IgE- dependent chemotactic factor, mediate
IgE-dependent constriction of human bronchi32)-36).
Significant influence of dietary PUFA to the concen-
tration of plasma IgE has been demonstrated in several
reports37)38). Gosset P et al. have demonstrated that
IgE-dependent stimulation of alveolar macrophages
(AMs) produces a neutrophil and eosinophil che-
motactic activity, present in a low molecular weight
fraction possibly related to LTs, and emphasized the
role of AMs in inflammatory lung processes during
allergic asthma33). Watanabe S et al. have reported that
IgE antibody response against egg albumin was
significantly lower in the high ALA diet group than in
the high LA diet group in mice and emphasized
suppressive effects of a high ALA diets on the severity
of immediate-type allergic hypersensitivity, together
with the suppressive effects on the formation of
lipid-derived allergic mediators, including LTs38). Our
study showed the "sensitive to diet" group had higher
IgE levels than the "insensitive to diet" group. This
indicates that ALA diet affect IgE-dependent allergic
reaction through LTs generation by leukocyte.
Many reports have demonstrated that the PUFA
-especially ALA- diets decreases serum cholesterol,
LDL-cholesteroI39)-43). And de Lorgeril M. et al. also
reported ALA diets increased serum albumin44). Re-
cent diets tends to contain high saturated fatty acids
and n-6 PUFAs and low n-3 PUFAs. Our study
1.9:1:2.1
14.1 :1:7.3
16.0:1:6.6
"insensi1:Ml to diet"
182.5:1:32.0 216.3:1:15.9
81.6:1:35.1 31.6:1:0.2
67.2:1:27.2 68.9:1:15.9
99.1:1:27.0 133.1:1:21.7
367.1 :1:90.2 430.5:1:62.3
0.46:1:0.16 0.46:1:0.25
187.9:1:22.8 232.3:1:16.6
7.09:1:0.80 7.04:1:0.43
3.89:1:0.21 3.58:1:0.35
1.28:1:0.30 1.1 5:1:0.31
1.7:1:2.6
14.3:1:9.1
16.0:1:9.5
"sensitive to diet" "insensitive to diet"
Discussion
"sensitive to diet"
ss
TS
AS
total cholesterol(lIlI!dl)*"
triglyceride(lIW!dl)
HOL-cholesterol(lIlI!dl)
LDL-ehoJesterol(lIlI!dl)*
IJ -lipoprotein(lIlI!dl)·
free fatty acid(mEq/ 0 )
phosphlipid(lIlI!dl)*"
total protein( a/dl)
albumin( & /dl)·
AlGratio
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showed the "sensitive to diet" group has significant
low serum cholesterol, LDL-cholesterol, phospholipid
and free fatty acid and high serum albumin compared
with the "insensitive to diet" group, suggesting that the
"sensitive to diet" group were considered to have had
n-3 rich diets before this study compared with the
"insensitive to diet" group.
In the present study, effects of ALA enriched perilla
seed oil on bronchial asthma were examined by
comparing with LA enriched corn oil. The results have
revealed that the effects of the dietary supplementation
with ALA on the bronchial asthma through the LTs
generation by leukocytes is affected by various factors
including respiratory condition and lipometabolism.
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n-3系脂肪敢食の気管支鴨息に対する海床効果 :
nl6系脂肪酸との比較
岡本 誠,芦田耕三,光延文裕,御船尚志,保崎
泰弘,柘野活史,原田誠之,湯本英一朗,高田真
吾,谷崎勝朗,片岡幹男1),原田実根1)
岡山大学医学部附属病院三朝分院内科,
り岡山大学医学部第二内科
気道への炎症性白血球の集合が気管支鳴息の病
態に関わっているC魚油などのn13系脂肪酸が白
血球の機能を抑制することにより気管支職息患者
に良好な効果をもたらし,薬剤の必要性を減じた
との報告がなされている｡α-リレノン酸を豊富
に含有するエゴマ油食の効果を調べるため,気管
支噂息患者23名に2コースの食事-リノール酸
の豊富なコーン油食を2週間摂取後,エゴマ油
食を2週間-を摂取してもらった｡嘱息患者は
2コースの食事間のロイコトリエン B4(LTB4),
CA(LTC4),B5(LTB5)の変化から2群-1群は食
事に対し感受性のある群,もう1つは感受性の
無い群一に分類した｡我々はこの2群を臨床的
に検討したところ,ピークフロー(PEP),1秒量
(FEVIO),IgE,性別,肥満率(0Ⅰ),血清総コレス
テロール,アルブミン,低比重リポ蛋白(LDL)
-コレステロール,♂-リポ蛋白,リン脂質にお
いて2群間に有意差が認められた｡
今回の研究から,これらの因子が,職息患者に
おいて,LTB4,LTC4,LTB5の産生に対する食
事療法の効果に影響を及ぼしていることが示唆さ
れた｡
キーワード:n-3系脂肪酸,エゴマ油,気管支噂
息,LTt14,LTC4
